JHS Svendgaard Laboratories Limited (JHS) Fair Value & Analysis
Consumer Defensive · IN · Market cap ₹663M
Fair value as of: Aug 13, 2026
From 2 valuation models · updated 4 days ago
Share price +20.9% over the past month.
Below-average quality, and screening another 51% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (₹5.35). The favourable scenario is already priced in.
- Weak quality (41/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range ₹6.55 – ₹38.15 · fair‑value band ₹3.40 – ₹5.35 · the ₹8.95 price screens above the ₹4.38 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
JHS Svendgaard Laboratories Limited (JHS) currently trades at ₹8.95, while our model-based Fair Value estimate is ₹4.38, implying the stock looks roughly 51.1% overvalued today. The Quality Score stands at 41/100 (below-average quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Over the trailing twelve months, JHS Svendgaard Laboratories Limited generated revenue of ₹1.1B at a net margin of -1.8%. Revenue grew 39.2% year over year. It earns a return on equity of -1.1%. The balance sheet holds a net cash position of ₹42.5M. Fundamentals as of Aug 13, 2026
Our scenario range runs from ₹3.40 (bear case) to ₹5.35 (bull case); at ₹8.95, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 36% below its 52-week high and 43% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -38% fair-value upside, at -51%, JHS screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 2 models by family
Widest divergence: Asset-Based (₹13.39) versus Multiples (₹5.44). Highest evidence: EV/EBITDA (54).
Notify me when JHS reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 41 · Market factors (momentum, volatility) 34
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades in, and sells a range of oral and dental products in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, whitening gels, talcum powders, sanitizers, detergents, and denture tablets.
Full company description
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades in, and sells a range of oral and dental products in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, whitening gels, talcum powders, sanitizers, detergents, and denture tablets. It also provides contract manufacturing services for oral care products. In addition, the company exports its products. JHS Svendgaard Laboratories Limited was founded in 1997 and is based in New Delhi, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
JHS Svendgaard Laboratories Limited reported revenue of ₹1.0B in FY2026 versus ₹855M in FY2022, a compound +4.4%/yr. Reported net income was −₹19.2M in FY2026.
JHS screens 51% overvalued. Compare with The Procter & Gamble Company →
Peer Group
Household & Personal Products · 252 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Procter & Gamble Company PG | $144.26 | $108.16 | -25% |
| Unilever PLC ULN | 1,080 MXN | 973.58 MXN | -10% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,063 | ₹789.46 | -62% |
| Essity AB ESSITYA | kr 276.50 | kr 250.02 | -10% |
| Godrej Consumer Products Limited GODREJCP | ₹936.90 | ₹367.64 | -61% |
| Marico Limited MARICO | ₹855.00 | ₹233.05 | -73% |
| APR Co 278470 | 397,000 KRW | 137,521 KRW | -65% |
| Dabur India Limited DABUR | ₹411.25 | ₹175.59 | -57% |
| PT Unilever Indonesia Tbk UNVR | 1,760 IDR | 1,928 IDR | +10% |
| Amorepacific Corporation 090430 | 135,700 KRW | 84,785 KRW | -38% |
Compare JHS Svendgaard Laboratories Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is JHS Svendgaard Laboratories Limited (JHS) overvalued or undervalued?
What is the fair value of JHS?
What is the quality score of JHS?
What is the revenue of JHS Svendgaard Laboratories Limited (JHS)?
What is the net profit margin of JHS?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track JHS Svendgaard Laboratories Limited and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.